查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1169179

鼻腔给药系统市场：按剂型、容器类型、系统类型、治疗应用、分销渠道、区域 - 规模、份额、展望、机会分析，2022-2030 年

Nasal Drug Delivery Systems Market, by Dosage Form, by Container Type, by System Type, by Therapeutics Application, by Distribution Channel and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
出版日期: | 出版商: Coherent Market Insights | 英文 156 Pages | 商品交期: 2-3个工作天内

价格
简介目录

鼻腔正在成为最有潜力和最有前途的药物输送途径之一，因为它具有避免肝臟初级代谢和最重要的患者便利等优势。 鼻腔给药系统用于治疗疼痛、急性偏头痛、过敏性和非过敏性鼻炎、鼻窦炎、感冒和鼻炎引起的鼻塞。 当需要起效或其他给药途径失败时，通常采用鼻内给药。 鼻腔给药系统可实现全身给药和无针疫苗接种。 液体滴鼻剂可以使用吸入器、滴管、喷雾泵、雾化器和雾化器给药。

市场动态

鼻腔给药系统研发活动的增加预计将在预测期内推动全球鼻腔给药系统市场的增长。 例如，2022 年 4 月 5 日，总部位于英国的合同开发和製造组织 (CDMO) Upperton Pharma Solutions 宣布，中小型创新者将拥有成功开发鼻用製剂所需的知识和能力。我们推出鼻腔给药开发平台“UpperNose”供使用。

此外，预计在预测期内，监管机构对产品批准的增加将推动鼻腔给药市场的增长。 例如，2021 年 10 月 18 日，处于商业化阶段的生物製药公司 Oyster Point Pharma, Inc. 宣布，美国食品药品监督管理局 (FDA) 批准 TYRVAYA（伐尼克兰溶液）鼻腔喷雾剂 0.03 mg 用于以下症状和体征：干眼症。宣布获批用于治疗 它是第一个也是唯一一个被批准用于治疗干眼症的鼻腔喷雾剂。 通过与胆碱能受体结合併激活三叉神经系统的副交感神经通路，据信可以增加基础泪液的产生，从而治疗干眼症。

这项研究的主要特点

  • 本报告对全球鼻腔给药系统市场进行了深入分析，提供了以 2021 年为基准年的预测期 (2022-2030) 的市场规模和復合年增长率 (CAGR%)。
  • 它还阐明了各个细分市场的潜在创收机会，并描述了该市场具有吸引力的投资建议矩阵。
  • 它还提供关键见解，例如市场驱动因素和製约因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采用的竞争战略。
  • 它根据以下参数介绍了全球鼻腔给药系统市场的领先企业：公司亮点、产品组合、主要亮点、财务业绩和战略。
  • 本研究涵盖的主要公司包括默克公司、葛兰素史克公司、阿斯利康公司、强生公司、辉瑞公司、百特国际公司、威朗製药国际公司、Becton、狄金森公司和诺华公司
  • 这份报告中的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。我猜。
  • 本研究报告面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
  • 利益相关者可以通过用于分析全球鼻腔给药系统市场的各种战略矩阵来促进他们的决策。

内容

第 1 章目的和先决条件

  • 调查目的
  • 先决条件
  • 缩写说明

第2章市场展望

  • 报告内容
    • 市场定义和范围
  • 执行摘要
    • 市场概况：按剂型分类
    • 按容器类型分类的市场概况
    • 市场概况：按系统类型
    • 市场概况：按治疗用途分类
    • 市场概况：按分销渠道
    • 市场概况：按地区
  • 连贯机会图 (COM)

第3章市场动态、规律及趋势分析

  • 市场动态
    • 司机
    • 约束因素
    • 市场机会
  • 主要亮点
  • 市场趋势
  • 害虫分析
  • 政府和非政府倡议
  • 流行病学

第 4 章全球鼻腔给药系统市场——冠状病毒 (COVID-19) 大流行的影响

  • 总体影响
  • 政府举措
  • COVID-19 对市场的影响

第 5 章全球鼻腔给药系统市场，按配方分列，2017-2030

  • 喷鼻剂
  • 滴鼻剂
  • 鼻用凝胶
  • 鼻粉
  • 其他

第 6 章按容器类型分列的鼻腔给药系统全球市场，2017-2030

  • 常压容器
  • 压力容器

第 7 章全球鼻腔给药系统市场：按系统类型，2017-2030

    • 2022 年和 2030 年市场份额分析 (%)
    • 2017-2030 年同比增长率分析
    • 细分趋势
  • 多剂量
    • 2017-2030 年市场规模、预测、同比增长率
  • 双倍剂量
    • 2017-2030 年市场规模、预测、同比增长率
  • 单位剂量
    • 2017-2030 年市场规模、预测、同比增长率

第 8 章全球鼻腔给药系统市场：按治疗用途分类，2017-2030

    • 2022 年和 2030 年市场份额分析 (%)
    • 2017-2030 年同比增长率分析
    • 细分趋势
  • 过敏性和非过敏性鼻炎
    • 2017-2030 年市场规模、预测、同比增长率
  • 鼻塞
    • 2017-2030 年市场规模、预测和同比增长率
  • 疫苗
    • 2017-2030 年市场规模、预测、同比增长率
  • 其他
    • 2017-2030 年市场规模和预测，同比增长率

第 9 章全球鼻腔给药系统市场：按分销渠道，2017-2030

    • 2022 年和 2030 年市场份额分析 (%)
    • 2017-2030 年同比增长率分析
    • 细分趋势
  • 医院药房
    • 2017-2030 年市场规模、预测、同比增长率
  • 零售药房
    • 2017-2030 年市场规模、预测、同比增长率
  • 在线药店
    • 2017-2030 年市场规模和预测，同比增长率

第 10 章按地区分列的鼻腔给药系统全球市场，2017-2030

  • 北美
  • 美国
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲地区
  • 欧洲
  • 英国
  • 德国
  • 意大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲地区
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 东盟
  • 澳大利亚
  • 韩国
  • 其他亚太地区
  • 中东
  • 海湾合作委员会
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中非
  • 南非

第11章竞争格局

  • 热图分析
  • 市场份额分析
  • 公司简介
    • Merck & Co., Inc.
    • GlaxoSmithKline plc
    • AstraZeneca plc
    • Johnson & Johnson
    • Pfizer Inc.
    • Baxter International, Inc.
    • Valeant Pharmaceuticals International, Inc.
    • Becton, Dickinson and Company
    • Novartis AG

第12章 章节

  • 调查手法介绍
  • 关于出版社
简介目录
Product Code: CMI1944

Nasal cavity is becoming one of the most potential and promising route of drug delivery, owing to its advantages such as bypassing the hepatic first-pass metabolism, and most importantly patient convenience. The nasal drug delivery systems used in the treatment of pain, acute migraine treatment, allergic and non-allergic rhinitis, and nasal congestion brought on by sinusitis, the common cold, or rhinitis. Nasal medication delivery is typically employed when a beginning of action is desired or when other routes of administration prove unsuccessful. Systemic drug administration and needle-free immunization is possible with the help of nasal drug delivery systems. It is possible to use inhalers, droppers, spray pumps, nebulizers, or atomizers to give liquid nasal solutions.

Market Dynamics

Increasing research and development activities for nasal drug delivery systems is expected to drive growth of the global nasal drug delivery system market over the forecast period. For instance, on April 5, 2022, Upperton Pharma Solutions, a U.K. based contract development and manufacturing organization (CDMO) had launched a nasal delivery development platform, UpperNose, for small and mid-sized innovators to access the knowledge and capabilities required for the successful development of nasal dose formulations.

Furthermore, increasing product approvals by regulatory authorities is expected to drive growth of the nasal drug delivery market over the forecast period. For instance, on October 18, 2021, Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company had announced that the U.S. Food and Drug Administration (FDA) had approved TYRVAYA (varenicline solution) Nasal Spray 0.03 mg for the treatment of the signs and symptoms of dry eye disease. TYRVAYA Nasal Spray is the first and only nasal spray approved for the treatment of dry eye disease. TYRVAYA Nasal Spray is believed to bind to cholinergic receptors to activate the trigeminal parasympathetic pathway resulting in increased production of basal tear film as a treatment for dry eye disease.

Key features of the study:

  • This report provides an in-depth analysis of the global nasal drug delivery systems market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global nasal drug delivery systems market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Merck & Co., Inc., GlaxoSmithKline plc, AstraZeneca plc, Johnson & Johnson, Pfizer Inc., Baxter International, Inc., Valeant Pharmaceuticals International, Inc., Becton, Dickinson and Company, and Novartis AG
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global nasal drug delivery systems market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nasal drug delivery systems market

Detailed Segmentation:

  • Global Nasal Drug Delivery Systems Market, By Dosage Form:
    • Nasal Spray
    • Nasal Drops
    • Nasal Gels
    • Nasal Powders
    • Others
  • Global Nasal Drug Delivery Systems Market, By Container Type:
    • Non-pressurized Containers
    • Pressurized Containers
  • Global Nasal Drug Delivery Systems Market, By System Type
    • Multi Dose
    • Bi Dose
    • Unit Dose
  • Global Nasal Drug Delivery Systems Market, By Therapeutics Application:
    • Allergic and Non-allergic Rhinitis
    • Nasal Congestion
    • Vaccination
    • Others
  • Global Nasal Drug Delivery Systems Market, By Distribution Channel
    • Hospitals Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Nasal Drug Delivery Systems Market, By Region:
    • North America
      • By Country
    • U.S.
    • Canada
    • Latin America
      • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
      • By Country
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Country
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
      • By Country
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
      • By Region/Country
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Merck & Co., Inc. *
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • GlaxoSmithKline plc
    • AstraZeneca plc
    • Johnson & Johnson
    • Pfizer Inc.
    • Baxter International, Inc.
    • Valeant Pharmaceuticals International, Inc.
    • Becton, Dickinson and Company
    • Novartis AG.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Dosage Form
    • Market Snapshot, By Container Type
    • Market Snapshot, By System Type
    • Market Snapshot, By Therapeutics Application
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Key Highlights
  • Market Trends
  • PEST Analysis
  • Government & Non-Government Initiatives
  • Epidemiology

4. Global Nasal Drug Delivery Systems Market- Impact of Coronavirus (Covid-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the market

5. Global Nasal Drug Delivery Systems Market, By Dosage Form, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Nasal Spray
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Nasal Drops
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Nasal Gels
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Nasal Powders
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Nasal Drug Delivery Systems Market, By Container Type, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Non-Pressurized Containers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Pressurized Containers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Nasal Drug Delivery Systems Market, By System Type, 2017 - 2030, (US$ Million)

    • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Multi Dose
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Bi-Dose
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Unit Dose
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

8. Global Nasal Drug Delivery Systems Market, By Therapeutic Application, 2017 - 2030, (US$ Million)

    • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Allergic and Non-Allergic Rhinitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Nasal Congestion
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Vaccination
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

9. Global Nasal Drug Delivery Systems Market, By Distribution Channel, 2017 - 2030, (US$ Million)

    • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Hospitals Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

10. Global Nasal Drug Delivery Systems Market, By Region, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By System Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By System Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By System Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • UK
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By System Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By System Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By System Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa

11. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
  • Company Profiles
    • Merck & Co., Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
    • GlaxoSmithKline plc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
    • AstraZeneca plc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
    • Johnson & Johnson
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
    • Pfizer Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
    • Baxter International, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
    • Valeant Pharmaceuticals International, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
    • Becton, Dickinson and Company
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
    • Novartis AG
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

12. Section

  • Research Methodology
  • About Us